JUAN
GÓMEZ-REINO CARNOTA
Investigador hasta 2007
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (81)
2022
-
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review
Seminars in Arthritis and Rheumatism, Vol. 52
2019
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
Clinical Microbiology and Infection, Vol. 24, pp. S10-S20
2016
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
2013
-
Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico
Reumatologia Clinica, Vol. 9, Núm. 5, pp. 281-296
2012
-
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: A case-control study
Arthritis Research and Therapy, Vol. 14, Núm. 2
-
Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study
PLoS ONE, Vol. 7, Núm. 9
2011
2009
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
Arthritis Research and Therapy, Vol. 11, Núm. 2
-
Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583
-
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA
Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595
-
Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study
Arthritis Research and Therapy, Vol. 11, Núm. 3
-
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors
Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564
2008
-
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274
-
Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts
Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 631-637
2007
-
Opposed independent effects and epistasis in the complex association of IRF5 to SLE
Genes and Immunity, Vol. 8, Núm. 5, pp. 429-438